Publication | Closed Access

A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer

Serum CreatininePrognostic BiomarkersSurgical OncologyMalignant DiseaseMedicineCancer ManagementPathologyNew IndexCystatin COncologyRadiation OncologyLung CancerCancer ResearchRadiologyHealth Sciences